Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kathleen S. Keegan is active.

Publication


Featured researches published by Kathleen S. Keegan.


Cell | 1997

Dynamic Changes of BRCA1 Subnuclear Location and Phosphorylation State Are Initiated by DNA Damage

Ralph Scully; Junjie Chen; Robert L. Ochs; Kathleen S. Keegan; Merl F. Hoekstra; Jean Feunteun; David M. Livingston

BRCA1 localizes to discrete nuclear foci (dots) during S phase. Hydroxyurea-mediated DNA synthesis arrest of S phase MCF7 cells led to a loss of BRCA1 from these structures. Ultraviolet light, mitomycin C, or gamma irradiation produced a similar effect but with no concurrent arrest of DNA synthesis. BARD1 and Rad51, two proteins associated with the BRCA1 dots, behaved similarly. Loss of the BRCA1 foci was accompanied by a specific, dose-dependent change(s) in the state of BRCA1 phosphorylation. Three distinct DNA damaging agents preferentially induced this change in S phase. The S phase BRCA1 phosphorylation response to DNA damage occurred in cells lacking, respectively, two DNA damage-sensing protein kinases, DNA-PK and Atm, implying that neither plays a prime role in this process. Finally, after BRCA1 dot dispersal, BRCA1, BARD1, and Rad51 accumulated, focally, on PCNA+ replication structures, implying an interaction of BRCA1/BARD1/Rad51 containing complexes with damaged, replicating DNA. Taken together, the data imply that the BRCA1 S phase foci are dynamic physiological elements, responsive to DNA damage, and that BRCA1-containing multiprotein complexes participate in a replication checkpoint response.


Proceedings of the National Academy of Sciences of the United States of America | 1998

Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control

Jocyndra A. Wright; Kathleen S. Keegan; Daniel R. Herendeen; Nicola J. Bentley; Antony M. Carr; Merl F. Hoekstra; Patrick Concannon


Archive | 2005

Compounds useful for inhibiting chk1

Kathleen S. Keegan; Edward A. Kesicki; John Joseph Gaudino; Adam Wade Cook; Scott Douglas Cowen; Laurence E. Burgess


Archive | 2002

Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chamosensitizers

Kathleen S. Keegan; Edward A. Kesicki; John Joseph Gaudino; Adam Wade Cook; Scott Douglas Cowen; Laurence Edward Burgess


Archive | 2004

Use of chk1 inhibitors to control cell proliferation

Darcey Clark; Kathleen S. Keegan; Scott Peterson; Margaret Weidner


Archive | 2001

ATR-2 cell cycle checkpoint

Kate Loughney; Kathleen S. Keegan


Archive | 2013

Méthodes d'utilisation d'inhibiteurs de cycle cellulaire pour moduler une ou plusieurs propriétés d'une culture cellulaire

Zhimei Du; John D. McCarter; Pranhitha Reddy; Andrew William Snowden; Lawrence R. McGee; John G. Allen; David Treiber; Kathleen S. Keegan; Zhihong Li


Archive | 2012

Doubles inhibiteurs tricycliques fusionnés de cdk 4/6 et de flt3

Xiaoqi Chen; Kang Dai; Jason Duquette; Michael W. Gribble; Justin Huard; Kathleen S. Keegan; Zhihong Li; Sarah E. Lively; Lawrence R. McGee; Mark L. Ragains; Xianghong Wang; Margaret Weidner; Jian Zhang


Archive | 2012

DEHYDRATED tricyclic DUALINHIBITORER OF CDK 4/6 AND FLT3

Xiaoqi Chen; Kang Dai; Michael W. Gribble; Zhihong Li; Sarah E. Lively; Lawrence R. McGee; Xianghong Wang; Margaret Weidner; Jian Zhang; Kathleen S. Keegan; Jason Duquette; Justin Huard; Mark L. Ragains


Archive | 2012

Fusionierte tricyclische duale inhibitoren von cdk 4/6 und flt3

Xiaoqi Chen; Kang Dai; Jason Duquette; Michael W. Gribble; Justin Huard; Kathleen S. Keegan; Zhihong Li; Sarah E. Lively; Lawrence R. McGee; Mark L. Ragains; Xianghong Wang; Margaret Weidner; Jian Zhang

Collaboration


Dive into the Kathleen S. Keegan's collaboration.

Top Co-Authors

Avatar

Edward A. Kesicki

Infectious Disease Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Scott Peterson

Los Alamos National Laboratory

View shared research outputs
Researchain Logo
Decentralizing Knowledge